As of 2026-04-19, the Relative Valuation of Immunic Inc (IMUX) is - USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.00 USD, the upside of Immunic Inc based on Relative Valuation is -.
The range of the Relative Valuation is - USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-04-17 | -1.34 |
| 2026-04-16 | -1.34 |
| 2026-04-15 | -1.49 |
| 2026-04-14 | -1.58 |
| 2026-04-13 | -1.64 |
| 2026-04-10 | -1.57 |
| 2026-04-09 | -1.73 |
| 2026-04-08 | -1.60 |
| 2026-04-07 | -1.60 |
| 2026-04-06 | -1.57 |
| 2026-04-02 | -1.56 |
| 2026-04-01 | -1.54 |
| 2026-03-31 | -1.49 |
| 2026-03-30 | -1.38 |
| 2026-03-27 | -1.46 |
| 2026-03-26 | -1.69 |
| 2026-03-25 | -1.77 |
| 2026-03-24 | -1.68 |
| 2026-03-23 | -1.57 |
| 2026-03-20 | -1.48 |
| 2026-03-19 | -1.56 |
| 2026-03-18 | -1.54 |
| 2026-03-17 | -1.61 |
| 2026-03-16 | -1.56 |
| 2026-03-13 | -1.57 |
| 2026-03-12 | -1.84 |
| 2026-03-11 | -1.95 |
| 2026-03-10 | -1.73 |
| 2026-03-09 | -1.68 |
| 2026-03-06 | -1.65 |
| 2026-03-05 | -1.49 |
| 2026-03-04 | -1.57 |
| 2026-03-03 | -1.44 |
| 2026-03-02 | -1.42 |
| 2026-02-27 | -1.37 |
| 2026-02-26 | -1.27 |
| 2026-02-25 | -1.22 |
| 2026-02-24 | -1.21 |
| 2026-02-23 | -1.16 |
| 2026-02-20 | -1.26 |
| 2026-02-19 | -1.31 |
| 2026-02-18 | -1.18 |
| 2026-02-17 | -1.23 |
| 2026-02-13 | -1.23 |
| 2026-02-12 | -1.17 |
| 2026-02-11 | -1.00 |
| 2026-02-10 | -1.07 |
| 2026-02-09 | -0.96 |
| 2026-02-06 | -0.83 |
| 2026-02-05 | -0.79 |